Keyphrases
Adaptation
29%
AMSTAR
22%
Bivariate Regression
9%
Clinical Practice Guidelines
33%
Clinical Trials
6%
Cochrane
11%
Cochrane Central Register of Controlled Trials
9%
Cochrane Collaboration
9%
Cochrane Systematic Review
16%
Collaboration Risk
9%
Completion Rate
11%
Consolidated Standards of Reporting Trials (CONSORT)
35%
Data Abstraction
6%
Embase
9%
Failure Report
6%
Fitting Trial
6%
High Risk
6%
Inclusion Criteria
12%
Incomplete Reporting
69%
Journal Publishing
33%
Measuring Instrument
5%
MEDLINE
9%
Meta-analysis
31%
Meta-epidemiological Study
100%
Metastatic Melanoma
33%
Methodological Quality
33%
Missing Data
6%
Multiple Sclerosis
66%
Neurology
33%
Neuroscience
8%
Non-Cochrane
16%
Patient Perspective
13%
Patient-reported Outcomes
100%
Peripheral Nerve Block
33%
Predatory Journals
33%
Predatory Publications
16%
PubMed
9%
Quality of Life
6%
Randomized Controlled Trial
100%
Rayyan
6%
Reporting Item
27%
Reporting Quality
93%
Risk of Bias
16%
Sectional Analysis
66%
Systematic Meta-analysis
31%
Trial Characteristics
12%
Trial Outcomes
6%
Trial Publication
9%
Trialists
6%
Underreported
6%
Medicine and Dentistry
Checklist
7%
Clinical Trial
6%
Clinician
12%
Combination Therapy
5%
Cross Sectional Study
33%
Cutaneous Melanoma
33%
Meta-Analysis
8%
Multiple Sclerosis
66%
Patient-Reported Outcome
100%
Peripheral Nerve Block
33%
Quality of Life
6%
Randomized Controlled Trial
100%
Systematic Review
33%
Nursing and Health Professions
Checklist
7%
Cochrane Library
12%
Combination Therapy
5%
Cutaneous Melanoma
33%
Embase
12%
Meta Analysis
10%
Multiple Sclerosis
66%
Nerve Block
33%
Patient-Reported Outcome
100%
Practice Guideline
36%
Quality of Life
9%
Sample Size
11%
Systematic Review
66%
